Back to 
Balyasny Asset Management L.P.
Balyasny Asset Management L.P.
KYMR
Showing 0 of 7 quarters
Position history for Balyasny Asset Management L.P.'s holdings in Kymera Therapeutics, Inc.
No. Balyasny Asset Management exited its KYMR (Kymera Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 22,677 shares worth $577,356. Balyasny Asset Management first reported KYMR in Q1 2021 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.